1. Gilman, SC and Lewis, AJ (1986). Immunopharmacological approaches to drug develoment. In: Drug Discovery and Development ( Williams, M and Malick, J, eds.) ( New Jersey: Human Press) (In press )
2. Masek, K (1983). Current status of drugs which modulate the immune response. Trends Pharmacol. Sci., 4, 318
3. Hadden, JW (1983). Characterization of in¢nunotherapeutic agents: an over- view. In: Advances in Immunopharmacology, Vol. 2 ( Hadden, JW, Chedid, L, Dukor, P, Spreafico, F and Willoughby, D, eds.). ( Oxford: Pergamon Press ), p. 691
4. Florentin, IM, Bruley-Rossett, M, Schulz, J, Davigny, M, Kiger, N and Mathe G (1981). Attempt at functional classification of chemically-defined immunomodulators. In: Advances in Inununopharmacology ( Hadden JW, Chedid, K, Mullen, P and Spreafico, F eds), ( Oxford: Pergamon Press ), p. 311
5. Gilman, SC and Lewis, AJ (1985). Immunomodulatory drugs in the treatment of rheumatoid arthritis. In: Anti-inflammatory and Antirheumatic Drugs, Vol. 3 ( Rainsford, KD, ed), ( Boca Raton, FL: CRC Press ) p. 127